Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
Associations of genetic predictors for l-carnitine and acetyl-carnitine with potential confounders
It helps transport fatty acids to the muscles mitochondria so they can be used as energy
Storage Conditions
Esto suele ir acompaado de agotamiento, poca fuerza de agarre o prdida de peso involuntaria derivado de la disfuncin mitocondrial provocada por la reduccin de los niveles de L-Carnitina